Strategies to reduce out-of-pocket medication costs for Canadians with peripheral arterial disease.

"Competing interests: William McIntyre reports consulting fees from Tri-Med, and payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Servier Laboratories and Bayer. Noel Chan reports funding from the Canadian Institutes of Health Research and the Heart and Stroke Foundation, outside the submitted work, and honoraria for talks from Diagnostica Stago and Boehringer. Vinai Bhagirath reports an unrestricted educational grant from Pfizer, outside the submitted work, and honoraria from Bayer. Richard Whitlock reports grants from AtriCure and Bayer, outside the submitted work, consulting fees from PhaseBio Pharmaceuticals, Artivion and AtriCure, payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from AtriCure and LeMaitre Vascular, and support for attending meetings and/or travel from AtriCure and Boehringer Ingelheim. He has participated on a data safety monitoring board and advisory board for Artivion and PhaseBio. Sonia Anand reports consulting fees from Janssen Pharmaceuticals and Bayer, outside the submitted work. Emilie Belley-Côté reports grants or contracts from Bayer, BMS-Pfizer and Roche Diagnostics, outside the submitted work. No other competing interests were declared."